COOPERS CUPRAX SUSTAINED RELEASE COPPER SUPPLEMENT FOR CATTLE

Main information

  • Trade name:
  • COOPERS CUPRAX SUSTAINED RELEASE COPPER SUPPLEMENT FOR CATTLE
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • COOPERS CUPRAX SUSTAINED RELEASE COPPER SUPPLEMENT FOR CATTLE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
  • Therapeutic area:
  • NUTRITION & METABOLISM
  • Therapeutic indications:
  • MINERAL AND NUTRITIONAL ADDITIVE | ACETONAEMIA | ACTINOBACILLOSIS | AMINO ACID SUPPLEMENT | AMINO ACIDS | BONE FRAGILITY | BONE GROWTH | CALCIUM SUPPLEMENT | CARTILAGE STRENGTH | COPPER DEFICIENCY | EGG SHELL | FATTY ACID DEFICIENCY | FATTY LIVER | GLUCOSE | GRASS TETANY | HEPATOTOXIC DRUGS | HYPOCALCAEMIA | HYPOMAGNESAEMIA | ILEITIS | IODINE DEFICIENCIES | LACTATING | LAXATIVE | L-CARNITINE SUPPLEMENT | LIVER ABSCESS | LIVER DAMAGE | LYSINE DEFICIENCIES | MILK FEVER | MINERAL ADDITIVE | MYOPATHIES | MYOSITIS SYNDROME | PANGAMIC ACID | PHOSPHOROUS SUPPLEMENT | RICKETS | SELENIUM DEFICIENCY | SHELL STRENGTH | SOFT BONE DISEASE | VITAMIN B12 | VITAMIN D SUPPLEMENT | VITAMIN E DEFICIENCIES | ZINC DEFICIENCIES

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 36195
  • Last update:
  • 09-08-2016

6-11-2018

FDA Approves Experior for Reduction of Ammonia Gas Released from Beef Cattle Waste

FDA Approves Experior for Reduction of Ammonia Gas Released from Beef Cattle Waste

FDA announced today the approval of Experior (lubabegron Type A medicated article), a beta-adrenergic agonist/antagonist drug that, when fed to beef cattle under specific conditions, results in less ammonia gas released as a by-product of their waste.

FDA - U.S. Food and Drug Administration

30-7-2018

ANSES recommends that certain populations avoid the consumption of food supplements containing melatonin

ANSES recommends that certain populations avoid the consumption of food supplements containing melatonin

Under the national nutrivigilance scheme, reports of adverse effects likely to be associated with the consumption of food supplements containing melatonin have been brought to the attention of ANSES. A retrospective analysis of these reports, combined with the considerable level of consumption of this type of supplement, led ANSES to conduct an assessment of the potential health risks. In its Opinion of February 2018, the Agency highlighted the existence of populations and situations at risk, for which t...

France - Agence Nationale du Médicament Vétérinaire

There are no news related to this product.